EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Up 295.3% in April

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totaling 20,151 shares, a growth of 295.3% from the April 15th total of 5,098 shares. Based on an average trading volume of 301,668 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.

EssilorLuxottica Stock Performance

Shares of ESLOY stock traded up $2.15 during trading hours on Wednesday, hitting $99.72. The stock had a trading volume of 26,876 shares, compared to its average volume of 118,723. EssilorLuxottica has a one year low of $96.56 and a one year high of $186.81. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. The stock’s 50-day moving average price is $114.63 and its two-hundred day moving average price is $146.97.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft assumed coverage on EssilorLuxottica in a research report on Tuesday. They issued a “hold” rating on the stock. Finally, Kepler Capital Markets upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Thursday, January 15th. Two investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, EssilorLuxottica has a consensus rating of “Buy”.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.